Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637504 · ClinicalTrials.gov registry record · NA
Feasibility of a Mobile Medication Plan Application in CF Patient Care
A NA study of Cystic Fibrosis and Cystic Fibrosis in Children, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 5
- Study locations
NCT03637504 is a NA study of Cystic Fibrosis and Cystic Fibrosis in Children that has completed, run by Boston Children's Hospital. The registered enrollment target is 105 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (41% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT03637504, a NA study of Cystic Fibrosis and Cystic Fibrosis in Children, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a pilot, multicenter, prospective, randomized controlled study to evaluate the feasibility of an innovative medication adherence intervention utilizing a web-based, mobile medication management application \[MedActionPlan® (MAP)\] to encourage self-management by reinforcing adherence and education about treatment regimens in Participants with cystic fibrosis (CF) (ages 12 years and older). Outcomes of interest for this study are 1) feasibility of MAP in real-world setting which will be evaluated using patient/caregiver and clinician feedback regarding value, ease of use, and challenges with use, 2) effect of MAP on patient/caregiver knowledge and perception of medication use, 3) effect of MAP on adherence to inhaled and oral medications used in chronic management of CF. Preliminary data regarding outcomes on exacerbations, lung function, and health care system utilization (e.g., emergency department visits, hospitalization) will also be examined as part of this study.
Conditions Studied
Interventions
- BEHAVIORAL MedActionPlan®
Study Locations (5)
Alabama
- Children's of Alabama - Birmingham
Arizona
- University of Arizona and Banner Health - Tucson
California
- Lucille Packard Children's Hospital Stanford - Stanford
Maryland
- Johns Hopkins University - Baltimore
New York
- University at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03637504
The ClinicalTrials.gov registry entry for NCT03637504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (41% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which MedActionPlan® is the first listed.
NCT03637504 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Alabama, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT03637504 about?
NCT03637504 is a clinical study titled "Feasibility of a Mobile Medication Plan Application in CF Patient Care". This is a pilot, multicenter, prospective, randomized controlled study to evaluate the feasibility of an innovative medication adherence intervention utilizing a web-based, mobile medication management application \[MedActionPlan® (MAP)\] to encourage self-management by reinforcing adherence and edu...
What is the current status of trial NCT03637504?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2018-09-05. Estimated completion is 2021-06-30.
What conditions does trial NCT03637504 study?
This clinical trial studies the following conditions: Cystic Fibrosis, Cystic Fibrosis in Children.
What interventions are being tested in trial NCT03637504?
The interventions under investigation include: MedActionPlan® (BEHAVIORAL).
Who is sponsoring clinical trial NCT03637504?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03637504 being conducted?
This trial has 5 study locations across Alabama, Arizona, California, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
FEED-Cystic Fibrosis (FEED-CF)
RECRUITING · NA
-
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
RECRUITING · NA
-
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
RECRUITING · NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.